Antibodies
11 October 2010
Ablynx and Merck Serono Enter Into Second Agreement to Co-Discover and Co- Develop Nanobodies(R)11 October 2010
Integrated Analysis Demonstrates That Denosumab Delays the Onset of Bone Complications Compared to Zometa11 October 2010
Results of a Randomized Phase II Study with Erbitux in Breast Cancer Highlighted in ESMO 2010 Presidential Symposium11 October 2010
ImmunoGen, Inc. Announces Presentation of Encouraging Clinical Data for Lorvotuzumab Mertansine at ESMO Annual Meeting11 October 2010
Micromet Announces FDA Acceptance of Investigational New Drug Application for BiTE Antibody MT111/MEDI-56511 October 2010
Abbott Reports Psoriasis Phase III Results of its Investigational IL-12/23 Inhibitor Briakinumab (ABT-874)7 October 2010
Privigen Demonstrates Efficacy and Tolerability Among Patients With Various Immunodeficiencies, Data Show7 October 2010
Study Demonstrates Safety and Efficacy of Subcutaneous Vivaglobin as First-Line Therapy for Primary Immunodeficiency5 October 2010
Clinical trials commence for melanoma in UK and USA1 October 2010
Neogenix Oncology to Commence Phase I Trial for Therapeutic Antibody for Pancreatic and Colorectal Cancer30 September 2010
AVEO Pharmaceuticals Regains Worldwide Rights to Develop and Commercialize Anti-HGF Antibody Candidate AV-29930 September 2010
Peregrine and Affitech to Amend License Agreements to Expedite Development of Novel Fully Human Anti-VEGF Antibody AT001/R8430 September 2010
Ablynx Initiates Phase II Clinical Trial for Ttp29 September 2010
XOMA 052 Phase 2a Trial Enrollment Completed28 September 2010
Morphotek, Inc. Announces Selection of a Therapeutic Monoclonal Antibody for Clinical Development under Terms of Collaboration with Human Genome Sciences27 September 2010
Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI Label in Treatment of Rheumatoid ArthritisNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports